Nifty Pharma Gains 1.49% as Large Caps Lead Broad Sector Advance
MarketPulse Summary: Nifty Pharma gained 1.49% (390.85 points) to 26579.25, with 99 of 130 stocks advancing against 30 declining. Large caps outperformed, with the top 10 by market capitalization averaging 2.09% versus 1% for smaller stocks. The market-cap-weighted change was 1.33%, while the median stock rose 1.02%.
📊 Key Numbers
📈 Sector Performance
| Metric | Value |
|---|---|
| Index Level | 26,579.25 |
| Previous Close | 26,188.40 |
| Change | +1.49% |
| Change Points | 390.85 |
🎯 What drove the move?
Market reports provided contextual factors around the sector move, but the available evidence does not establish a single confirmed catalyst.
📊 Market Breadth
Across the broader Pharma stock universe used in this analysis, 30 of 130 stocks declined, while 99 advanced and 1 remained unchanged. Decliners represented 23.08%, compared with 76.15% for advancers. The breadth score was 53.08, indicating strongly positive internal conditions. This universe should not be treated as the official index constituent universe unless separately verified.
| Category | Stocks | Share |
|---|---|---|
| Advancing | 99 | 76.15% |
| Declining | 30 | 23.08% |
| Unchanged | 1 | — |
| Breadth Score | 53.08 | |
🏢 Large Caps vs Smaller Stocks
The top 10 companies by market capitalization averaged 2.09%, while smaller stocks averaged 1.00%. The market-cap-weighted change was 1.33%, compared with a median change of 1.02% and a simple average of 1.08%. The leadership condition was large caps outperforming. The divergence indicates that the magnitude of the sector move was concentrated in larger companies.
🚀 Top Gainers
| Stock | LTP | % |
|---|---|---|
|
AHCL
Anlon Healthcare Limited
|
₹21.84 | +8.98% |
|
MOREPENLAB
Morepen Laboratories Limited
|
₹120.56 | +5.08% |
|
ANUHPHR
Anuh Pharma Limited
|
₹93.68 | +5.00% |
|
VALIANTLAB
Valiant Laboratories Limited
|
₹122.75 | +5.00% |
|
PAR
Par Drugs And Chemicals Limited
|
₹133.54 | +4.99% |
📉 Top Losers
| Stock | LTP | % |
|---|---|---|
|
SIGACHI
Sigachi Industries Limited
|
₹29.33 | -5.87% |
|
ORTINGLOBE
ORTIN GLOBAL LIMITED
|
₹16.45 | -4.64% |
|
ENTERO
Entero Healthcare Solutions Limited
|
₹1,666.60 | -3.76% |
|
ALBERTDAVD
Albert David Limited
|
₹838.45 | -2.56% |
|
ALPA
Alpa Laboratories Limited
|
₹59.64 | -2.42% |
🏦 Largest Companies
Among the top gainers, Anlon Healthcare Limited gained 8.98% to 21.84, Morepen Laboratories Limited gained 5.08% to 120.56, Anuh Pharma Limited gained 5.00% to 93.68. On the losing side, Sigachi Industries Limited fell 5.87% to 29.33, ORTIN GLOBAL LIMITED fell 4.64% to 16.45, Entero Healthcare Solutions Limited fell 3.76% to 1,666.60. Among the largest companies, Sun Pharmaceutical Industries Limited gained 0.74%, Divi's Laboratories Limited gained 1.80%, Torrent Pharmaceuticals Limited gained 1.30%, Zydus Lifesciences Limited gained 2.49%, Cipla Limited gained 1.35%. The available research does not establish specific reasons for individual stock moves.
| Stock | Market Cap | LTP | % |
|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical Industries Limited
|
4,60,672cr | ₹1,867.30 | +0.74% |
|
DIVISLAB
Divi's Laboratories Limited
|
2,45,266cr | ₹9,323.00 | +1.80% |
|
TORNTPHARM
Torrent Pharmaceuticals Limited
|
1,92,086cr | ₹4,875.00 | +1.30% |
|
ZYDUSLIFE
Zydus Lifesciences Limited
|
1,18,803cr | ₹1,135.10 | +2.49% |
|
CIPLA
Cipla Limited
|
1,14,999cr | ₹1,376.30 | +1.35% |
|
LAURUSLABS
Laurus Labs Limited
|
1,04,740cr | ₹1,948.10 | +2.24% |
|
LUPIN
Lupin Limited
|
99,295cr | ₹2,098.10 | +2.60% |
|
MANKIND
Mankind Pharma Limited
|
98,413cr | ₹2,300.00 | +2.40% |
|
DRREDDY
Dr. Reddy's Laboratories Limited
|
98,325cr | ₹1,175.00 | +3.07% |
|
AUROPHARMA
Aurobindo Pharma Limited
|
94,667cr | ₹1,690.00 | +2.86% |
📝 What the data suggests
Large Caps Lead Pharma
The data shows strongly positive internal sector conditions. The relationship between breadth, large-cap performance and smaller-stock performance should be considered when interpreting the move.
👀 What to watch next
The divergence between large-cap and smaller stocks remains relevant to the sector's internal structure. The large caps lead pharma remains the key data-supported theme.
📊 Track Live Markets
Real-time Nifty data, sector performance, market breadth, stock movers and AI-powered analysis.
Open Dashboard →Data generated at 17 Sept 2026. Not investment advice.